Novel treatment targets for COVID-19: Contribution from molecular psychiatry.

Schmidt, Ulrike; Rein, Theo

Schmidt, Ulrike; Rein, Theo.

Schmidt U; Klinik für Psychiatrie und Psychotherapie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Rein T; Klinik für Psychiatrie und Psychotherapie, Georg-August Universität Göttingen, Göttingen, Germany.

World J Biol Psychiatry ; 21(7): 572-575, 2020 09.

Article in English | MEDLINE | ID: covidwho-631479

Subject(s)

Brain Diseases/therapy; Coronavirus Infections/therapy; Nervous System Diseases/therapy; Pneumonia, Viral/therapy; Biological Psychiatry/methods; Brain Diseases/etiology; COVID-19; Coronavirus Infections/complications; Humans; Molecular Biology/methods; Nervous System Diseases/etiology; Pandemics; Pneumonia, Viral/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Brain Diseases / Coronavirus Infections / Nervous System Diseases Topics: Long Covid Limits: Humans Language: English Journal: World J Biol Psychiatry Journal subject: Psychiatry Year: 2020 Document Type: Article Affiliation country: 15622975.2020.1779344

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google